Liyun Li
机构：State Grid Corporation of China (China), Shandong Jianzhu University · ORCID：0000-0001-5841-1142
发表论文 161 篇 · 总被引 2733 次 · h-index 20
代表论文
- Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial (2024 · BMJ · 被引 256)
- CD19 CAR T-Cell Therapy in Refractory Autoimmune Hemolytic Anemia (2024 · Blood · 被引 10)
- Study on the predictive model of delirium risk after surgery for elderly hip fractures based on meta-analysis (2024 · European Geriatric Medicine · 被引 7)
- Crack coalescence and failure behaviors in slate specimens containing a circular cavity and a pre-existing flaw pair under uniaxial compression (2024 · Theoretical and Applied Fracture Mechanics · 被引 7)
- Epigenetic modifications in vascular inflammation (2025 · Frontiers in Immunology · 被引 5)
- Association of Dietary Profiles and Nutritional Status Among Patients with Hematologic Diseases: A Prospective Cohort Study (2024 · Blood · 被引 4)